NWM
GILD icon

Nova Wealth Management’s Gilead Sciences GILD Stock Holding History

Nova Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$6.92K – 589
2026
Q1 		$6.92K Sell
50
-23
-32% -$3.22K ﹤0.01% 398
2025
Q4 		$8.98K Hold
73
– – 0.01% 361
2025
Q3 		$8.12K Hold
73
– – 0.01% 369
2025
Q2 		$8.11K Buy
73
+57
+356% +$6.07K 0.01% 385
2025
Q1 		$1.79K Buy
+16
New +$1.65K ﹤0.01% 454

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Nova Wealth Management's GILD Position: Q2 2026 in Review

Nova Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 50 shares — an estimated $6.92K sold.

Nova Wealth Management first reported a position in GILD in Q1 2025 and held it in 5 quarters. The position peaked at $8.98K in Q4 2025. 457 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nova Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Nova Wealth Management sold 50 Gilead Sciences shares in Q2 2026, an estimated $6.92K.
  • Nova Wealth Management first reported a position in Gilead Sciences in Q1 2025 and held it in 5 quarters.
  • Nova Wealth Management's Gilead Sciences position peaked at $8.98K in Q4 2025.
  • 457 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.